The Clinical Evaluation of Continuous Assistance Offered to Older People Living Independently.
NCT ID: NCT01218373
Last Updated: 2017-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2010 participants
INTERVENTIONAL
2010-12-01
2013-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
NCT05961319
An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly
NCT00217113
Evaluation of a Health Monitoring Platform for Elderly in Home Care Context
NCT04514536
Autonomous At Home with Occupational Therapy Support and Assistive Devices
NCT06819982
Technologies to Reduce Caregiver Burden for Informal Caregivers of People With Dementia
NCT02733939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
HOMESWEETHOME services are expected to result in an outcome that is superior to usual care alone in reducing deterioration of health related quality of life and function associated with age and chronic disease. This effect will be measured by assessing different outcomes.
The clinical evaluation of the HOMESWEETHOME project sets out to assess the long-term effects of continuous assistance offered by the HOMESWEETHOME services to older people living independently. The trial will test the hypothesis that while providing a level of safety equivalent to or better than that enjoyed in older people"s homes, there is a significant positive effect on the quality of life (QoL) and the duration of independently living of older people.
The study is conducted in four sites within the European Union, these sites will have the number of participants randomised into Intervention Group and Control Group, as follows:
* Belgium - City of Antwerp 30 + 30
* Catalonia - Town of Badalona 15 + 15
* Ireland - North Eastern Region 30 + 30
* Italy - Town of Latina 30 + 30 The main inclusion criteria for participants" entry into the trial will be based on frailty. Frailty is a concept associated with adverse outcomes such as higher morbidity, more hospitalisations and falls, and a lower quality of life. Furthermore, frailty predicts - better than age - the evolution to disability and death. Participants must also be 65 years or over, and living at home. The main reasons for excluding participants will be based on their physical or mental (in)ability to take part.
The primary clinical outcome for the trials will be measured based on the Health Status Questionnaire Short Form 36 (SF-36) (v2).
Secondary outcomes will be measured using Edmonton Frailty Scale (EFS), Comprehensive Geriatric Assessment (CGA), Clinical Global Impression (CGI), and Hospital Anxiety and Depression Scale (HADS). A number of medical events will also be measured.
Measurements will be taken at trial start, trial mid-term, and trial end. Measurements will be entered, anonymously, into a database for analysis of results. The trial population size has been subjected to a statistical power analysis, to ensure statistical significance of project results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group: HOMESWEETHOME services
Monitoring and alarm handling services. eInclusion services. Domotica services. Daily scheduler. Navigation services. Cognitive training services. Non-technology based services.
HOMESWEETHOME Services
Monitoring and alarm handling services. eInclusion services. Domotic services. Daily scheduler. Navigation services. Cognitive training services. Non-technology based services.
Control Group: No HOMESWEETHOME services
Normal care.
No HOMESWEETHOME services installed
Normal care and healthcare without HOMESWEETHOME services.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HOMESWEETHOME Services
Monitoring and alarm handling services. eInclusion services. Domotic services. Daily scheduler. Navigation services. Cognitive training services. Non-technology based services.
No HOMESWEETHOME services installed
Normal care and healthcare without HOMESWEETHOME services.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living at home or in the community, i.e. not in a nursing home, acute or sub-acute clinical or care setting.
* Scoring "mildly frail" or "moderately frail" in Edmonton Frail Scale (EFS).
Exclusion Criteria
* Living situation not suitable for independent living (also including long planned durations of absence from home).
* Physically, mentally or otherwise unable to use and / or operate HOMESWEETHOME devices / instruments.
* Unable to administer self-assessment measurements (e.g. monitoring vital signs; questionnaires).
* Significant impairment of language comprehension or expression (e.g. aphasia).
* Active medical illness with a significant shortened life expectancy (\< 6 months), based on mortality prognosis2.
* Living without access to ISDN or ADSL service.
* Living with another HOMESWEETHOME participant in the same home.
* Completely dependent on others for the activities of daily living.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Netwerk Antwerpen (ZNA)
OTHER
EuroCross
UNKNOWN
Badalona Serveis Assistencials
OTHER
Department of Health, Generalitat de Catalunya
OTHER_GOV
Louth County Council
UNKNOWN
Health Services Executive North Eastern Area
UNKNOWN
TeleMedicina Rizzoli
UNKNOWN
Darco Servizi
UNKNOWN
Azienda USL di Latina
UNKNOWN
University of Roma La Sapienza
OTHER
Him SA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wouter A Keijser, MD
Role: STUDY_DIRECTOR
Him SA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ZNA
Antwerp, Flanders, Belgium
Netwell Centre
Dublin, , Ireland
Viale P.L. Nervi, Centro Commerciale Latinafiori, Torre Girasoli, 4100 Latina
Latina, Lazio Regon, Italy
Badalona Serveis Assistencials
Badalona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
250449
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
HSH-CLTRPR-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.